IL60332A - 3-amino-5-(4-pyridyl)-1,2,4-triazoles and pharmaceutical compositions comprising them - Google Patents

3-amino-5-(4-pyridyl)-1,2,4-triazoles and pharmaceutical compositions comprising them

Info

Publication number
IL60332A
IL60332A IL60332A IL6033280A IL60332A IL 60332 A IL60332 A IL 60332A IL 60332 A IL60332 A IL 60332A IL 6033280 A IL6033280 A IL 6033280A IL 60332 A IL60332 A IL 60332A
Authority
IL
Israel
Prior art keywords
triazoles
pyridyl
amino
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IL60332A
Other languages
English (en)
Other versions
IL60332A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL60332A0 publication Critical patent/IL60332A0/xx
Publication of IL60332A publication Critical patent/IL60332A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL60332A 1979-06-18 1980-06-17 3-amino-5-(4-pyridyl)-1,2,4-triazoles and pharmaceutical compositions comprising them IL60332A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/049,737 US4276297A (en) 1979-06-18 1979-06-18 Pyridylaminotriazole therapeutic agents

Publications (2)

Publication Number Publication Date
IL60332A0 IL60332A0 (en) 1980-09-16
IL60332A true IL60332A (en) 1983-09-30

Family

ID=21961428

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60332A IL60332A (en) 1979-06-18 1980-06-17 3-amino-5-(4-pyridyl)-1,2,4-triazoles and pharmaceutical compositions comprising them

Country Status (24)

Country Link
US (1) US4276297A (xx)
JP (1) JPS565477A (xx)
KR (2) KR840002173B1 (xx)
AR (2) AR225766A1 (xx)
AT (2) AT375655B (xx)
BE (1) BE883859A (xx)
CA (1) CA1140133A (xx)
CH (1) CH644375A5 (xx)
DE (1) DE3022302C2 (xx)
DK (1) DK258180A (xx)
ES (2) ES8105313A1 (xx)
FI (1) FI69842C (xx)
FR (1) FR2459241A1 (xx)
GB (1) GB2053910B (xx)
GR (1) GR68731B (xx)
IE (1) IE49913B1 (xx)
IL (1) IL60332A (xx)
IT (1) IT1140993B (xx)
LU (1) LU82527A1 (xx)
NL (1) NL182641C (xx)
PH (1) PH16875A (xx)
PT (1) PT71399A (xx)
SE (1) SE441745B (xx)
YU (2) YU41717B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR230994A1 (es) * 1981-08-31 1984-08-31 Pfizer Procedimiento para preparar compuesto de 3'-substituido-5'-(2-amino-4-piridil)-1',2',4'-triazol
JP2518515Y2 (ja) * 1993-09-22 1996-11-27 茂郎 槇島 水虫用医療包帯
US9440953B2 (en) * 2014-12-19 2016-09-13 OncoArendi Therapeutics Sp. z o.o. Substituted amino triazoles useful as acidic mammalian chitinase inhibitors
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1925654U (de) 1965-07-23 1965-10-21 Alfons Mann Zusatzeinrichtung fuer vergaser an benzinmotoren zur steigerung der motorenleistung.
CH521419A (de) * 1968-03-01 1972-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Azofarbstoffe
GB1264798A (xx) 1968-07-10 1972-02-23
US3647814A (en) * 1969-07-03 1972-03-07 Rohm & Haas Method for preparing 4-substituted-1 2 4-triazoles
NL7112373A (xx) * 1970-09-25 1972-03-28
NL7112372A (xx) * 1970-09-25 1972-03-28
GB1403866A (en) * 1971-12-06 1975-08-28 Wyeth John & Brother Ltd Derivatives of 3-amino-1,2,4-triazoles
US3879404A (en) * 1972-07-07 1975-04-22 John J Baldwin Certain 5-(pyridyl)-3(phenyl)-1,2,4-triazoles
US3873563A (en) * 1972-09-29 1975-03-25 Sakai Chemical Industry Co Method for manufacturing 4-amino-1,2,4-triazoles
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators

Also Published As

Publication number Publication date
SE8004498L (sv) 1980-12-19
ES492522A0 (es) 1981-06-01
CA1140133A (en) 1983-01-25
YU263382A (en) 1983-04-30
US4276297A (en) 1981-06-30
FR2459241A1 (fr) 1981-01-09
DK258180A (da) 1980-12-19
KR840002172B1 (ko) 1984-11-26
IE49913B1 (en) 1986-01-08
BE883859A (fr) 1980-12-17
JPS617426B2 (xx) 1986-03-06
NL182641C (nl) 1988-04-18
AR225766A1 (es) 1982-04-30
YU41717B (en) 1987-12-31
ES8201155A1 (es) 1981-12-01
GR68731B (xx) 1982-02-10
AR227436A1 (es) 1982-10-29
GB2053910B (en) 1983-04-20
KR840002173B1 (ko) 1984-11-26
CH644375A5 (fr) 1984-07-31
FR2459241B1 (xx) 1983-06-17
AT375655B (de) 1984-08-27
ES498821A0 (es) 1981-12-01
YU158780A (en) 1983-04-30
NL182641B (nl) 1987-11-16
IE801250L (en) 1980-12-18
DE3022302A1 (de) 1981-01-08
PT71399A (en) 1980-07-01
SE441745B (sv) 1985-11-04
JPS565477A (en) 1981-01-20
IT8022825A0 (it) 1980-06-17
IT1140993B (it) 1986-10-10
DE3022302C2 (de) 1984-03-01
NL8003496A (nl) 1980-12-22
ATA319280A (de) 1984-01-15
KR840004687A (ko) 1984-10-22
ES8105313A1 (es) 1981-06-01
IL60332A0 (en) 1980-09-16
GB2053910A (en) 1981-02-11
KR830002756A (ko) 1983-05-30
ATA307583A (de) 1984-01-15
PH16875A (en) 1984-04-02
FI69842C (fi) 1986-05-26
FI801929A (fi) 1980-12-19
YU41536B (en) 1987-08-31
FI69842B (fi) 1985-12-31
LU82527A1 (fr) 1981-02-03
AT375656B (de) 1984-08-27

Similar Documents

Publication Publication Date Title
GB2056971B (en) Delta/2-1,2,4-triazolin-5-one derivatives
NZ182230A (en) 1,3-diazoles and 1,2,4-triazoles and fungicidal compositions
NZ181916A (en) 1-substituted-1,2,4-triazoles and fungicidal compositions
IL57178A0 (en) 1,3,4-triazole derivatives their preparation and pharmaceutical compositions containing them
IL52692A (en) 1-phenethyl-1h-1,2,4-triazole derivatives and fungicidal compositions containing them
DE3064582D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives and pharmaceutical compositions containing them
NZ195006A (en) 2-carbonyloxy-3fluromethyl-1-phenoxy-1-triazolyl-butanes and fungicidal compositions
DE3068965D1 (en) 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
JPS567766A (en) Phenoxypyridine derivative* its manufacture and herbicidal composition containing same
DE3067564D1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
PH16288A (en) Benzodiazepine compounds and compositions thereof
NZ182414A (en) 1-(2-halo-2-phenylethyl)-1,2,4-triazoles and fungicidal compositions
IL59503A (en) 1,2,4-triazol derivatives,their preparation and pharmaceutical compositions containing them
IL62229A (en) 3-substituted-5-amino-1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
JPS5758675A (en) Herbicidal 3-benzylsulfonyl-1-diethylcarbamoyl- 1,2,4-triazole, herbicidal composition containing same and use
IL61603A0 (en) 2,3-indoledione derivatives their manufacture and pharmalceutical compositions containing them
IL60332A (en) 3-amino-5-(4-pyridyl)-1,2,4-triazoles and pharmaceutical compositions comprising them
PH17306A (en) 2,3,4,5-tetrahydro-1-benzoxepine-3,5-dione derivatives and processes for their preparation
ZA872720B (en) Derivative of 1,5-diphenyl-1h-1,2,4-triazole-3-carboxamide and herbicidal composition containing the same
NZ185908A (en) 1,2-disubstituted-1,2,4-triazolidine-3,5-diones and pharmaceutical compositions
DE3370622D1 (en) Triazole derivatives and compositions containing the same
NZ193909A (en) N-oximinoalkyl-anilides and fungicidal compositions
NZ182062A (en) 4-pyrazol-3-4l-4h-1,2,4-triazole derivatives and herbicidal compositions
PH15419A (en) Acyl-1h-1,2,4-triazole derivatives and compositions containing same
NZ188571A (en) 1,2,4-triazoles and fungicidal compositions